This house believes that: MARI/TAD is better than sentinel node biopsy after PST for cN+ patients

This house believes that: MARI/TAD is better than sentinel node biopsy after PST for cN+ patients

The increasing use and effectiveness of primary systemic treatment (PST) enables tailored locoregional treatment. About one third of clinically node positive (cN+) breast cancer patients achieve pathologic complete response (pCR) of the axilla, with higher rates observed in Human Epidermal growth fa...

Full description

Bibliographic Details
Main Authors: Annemiek K.E. van Hemert, Frederieke H. van Duijnhoven, Marie-Jeanne T.F.D. Vrancken Peeters
Format: Article
Language:English
Published: Elsevier 2023-10-01
Series:Breast
Subjects:
Breast cancer
Primary systemic treatment
Pathologic response
Tailored axillary treatment
Online Access:http://www.sciencedirect.com/science/article/pii/S0960977623005155

Internet

http://www.sciencedirect.com/science/article/pii/S0960977623005155

Similar Items